BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16170367)

  • 21. Neuregulin-induced expression of the acetylcholine receptor requires endocytosis of ErbB receptors.
    Yang XL; Huang YZ; Xiong WC; Mei L
    Mol Cell Neurosci; 2005 Feb; 28(2):335-46. PubMed ID: 15691714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells.
    Ostrander JH; Daniel AR; Lofgren K; Kleer CG; Lange CA
    Cancer Res; 2007 May; 67(9):4199-209. PubMed ID: 17483331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The C-terminus of the kinase-defective neuregulin receptor ErbB-3 confers mitogenic superiority and dictates endocytic routing.
    Waterman H; Alroy I; Strano S; Seger R; Yarden Y
    EMBO J; 1999 Jun; 18(12):3348-58. PubMed ID: 10369675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
    Badache A; Hynes NE
    Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Signal transduction pathways induced by heregulin in MDA-MB-453 breast cancer cells.
    Sepp-Lorenzino L; Eberhard I; Ma Z; Cho C; Serve H; Liu F; Rosen N; Lupu R
    Oncogene; 1996 Apr; 12(8):1679-87. PubMed ID: 8622888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nuclear localization and possible functions of receptor tyrosine kinases.
    Carpenter G
    Curr Opin Cell Biol; 2003 Apr; 15(2):143-8. PubMed ID: 12648669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis.
    Yen L; You XL; Al Moustafa AE; Batist G; Hynes NE; Mader S; Meloche S; Alaoui-Jamali MA
    Oncogene; 2000 Jul; 19(31):3460-9. PubMed ID: 10918604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The ErbB/HER family of protein-tyrosine kinases and cancer.
    Roskoski R
    Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The 44 kDa Pim-1 kinase directly interacts with tyrosine kinase Etk/BMX and protects human prostate cancer cells from apoptosis induced by chemotherapeutic drugs.
    Xie Y; Xu K; Dai B; Guo Z; Jiang T; Chen H; Qiu Y
    Oncogene; 2006 Jan; 25(1):70-8. PubMed ID: 16186805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dimerization is required for SH3PX1 tyrosine phosphorylation in response to epidermal growth factor signalling and interaction with ACK2.
    Childress C; Lin Q; Yang W
    Biochem J; 2006 Mar; 394(Pt 3):693-8. PubMed ID: 16316319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heregulin-beta is especially potent in activating phosphatidylinositol 3-kinase in nontransformed human mammary epithelial cells.
    Ram TG; Hosick HL; Ethier SP
    J Cell Physiol; 2000 Jun; 183(3):301-13. PubMed ID: 10797304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ErbB-4 and TNF-alpha converting enzyme localization to membrane microdomains.
    Thiel KW; Carpenter G
    Biochem Biophys Res Commun; 2006 Nov; 350(3):629-33. PubMed ID: 17027649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells.
    Tao RH; Maruyama IN
    J Cell Sci; 2008 Oct; 121(Pt 19):3207-17. PubMed ID: 18782861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of dual specificity kinase activity of DYRK1A.
    Walte A; Rüben K; Birner-Gruenberger R; Preisinger C; Bamberg-Lemper S; Hilz N; Bracher F; Becker W
    FEBS J; 2013 Sep; 280(18):4495-511. PubMed ID: 23809146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ligand-independent dimerization of the human prolactin receptor isoforms: functional implications.
    Gadd SL; Clevenger CV
    Mol Endocrinol; 2006 Nov; 20(11):2734-46. PubMed ID: 16840534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of heregulin signaling by an aptamer that preferentially binds to the oligomeric form of human epidermal growth factor receptor-3.
    Chen CH; Chernis GA; Hoang VQ; Landgraf R
    Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9226-31. PubMed ID: 12874383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel epidermal growth factor-like molecule containing two follistatin modules stimulates tyrosine phosphorylation of erbB-4 in MKN28 gastric cancer cells.
    Uchida T; Wada K; Akamatsu T; Yonezawa M; Noguchi H; Mizoguchi A; Kasuga M; Sakamoto C
    Biochem Biophys Res Commun; 1999 Dec; 266(2):593-602. PubMed ID: 10600548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential and synergistic effects of epidermal growth factor receptor antibodies on unliganded ErbB dimers and oligomers.
    Kozer N; Kelly MP; Orchard S; Burgess AW; Scott AM; Clayton AH
    Biochemistry; 2011 May; 50(18):3581-90. PubMed ID: 21495621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heregulins implicated in cellular functions other than receptor activation.
    Breuleux M; Schoumacher F; Rehn D; Küng W; Mueller H; Eppenberger U
    Mol Cancer Res; 2006 Jan; 4(1):27-37. PubMed ID: 16446404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. trans-Autophosphorylation by the isolated kinase domain is not sufficient for dimerization or activation of the dsRNA-activated protein kinase PKR.
    Wu S; Kaufman RJ
    Biochemistry; 2004 Aug; 43(34):11027-34. PubMed ID: 15323561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.